Melior Discovery has extensive capability in the area of in vivo pharmacology. 
Since 2005 Melior has evaluated hundreds of compounds in thousands of studies across dozens of animal models of human disease. We have applied this extensive know-how to pioneer theraTRACE^®, a unique, high throughput in vivo pharmacology platform that serves as a powerful drug repositioning platform. Melior offers access to individual animal models and our theraTRACE^® platform as contract research or on collaborative research basis.  We are a dedicated in vivo pharmacology CRO that strives to provide the highest quality service.